Onego Bio raised €14M in a funding round in Jul 2024. The company is based in Helsinki, Finland. Investors in the round: European Innovation Council (EIC) Accelerator Programme, Series A investors. Data as of 22 Sept 2026.
Reported in EUR — no conversion. €14M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
